microRNA therapies in cancer

MicroRNAs (miRNAs or miRs) are a family of small non-coding RNA species that have been implicated in the control of many fundamental cellular and physiological processes such as cellular differentiation, proliferation, apoptosis and stem cell maintenance. miRNAs regulate gene expression by the seque...

Descripción completa

Detalles Bibliográficos
Autor principal: Rothschild, Sacha I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452061/
https://www.ncbi.nlm.nih.gov/pubmed/26056576
http://dx.doi.org/10.1186/2052-8426-2-7
_version_ 1782374243042852864
author Rothschild, Sacha I
author_facet Rothschild, Sacha I
author_sort Rothschild, Sacha I
collection PubMed
description MicroRNAs (miRNAs or miRs) are a family of small non-coding RNA species that have been implicated in the control of many fundamental cellular and physiological processes such as cellular differentiation, proliferation, apoptosis and stem cell maintenance. miRNAs regulate gene expression by the sequence-selective targeting of mRNAs, leading to translational repression or mRNA degradation. Some microRNAs have been categorized as “oncomiRs” as opposed to “tumor suppressor miRs” Modulating the miRNA activities may provide exciting opportunities for cancer therapy. This review highlights the latest discovery of miRNAs involved in carcinogenesis as well as the potential applications of miRNA regulations in cancer treatment. Several studies have demonstrated the feasibility of restoring tumor suppressive miRNAs and targeting oncogenic miRNAs for cancer therapy using in vivo model systems.
format Online
Article
Text
id pubmed-4452061
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44520612015-06-09 microRNA therapies in cancer Rothschild, Sacha I Mol Cell Ther Review MicroRNAs (miRNAs or miRs) are a family of small non-coding RNA species that have been implicated in the control of many fundamental cellular and physiological processes such as cellular differentiation, proliferation, apoptosis and stem cell maintenance. miRNAs regulate gene expression by the sequence-selective targeting of mRNAs, leading to translational repression or mRNA degradation. Some microRNAs have been categorized as “oncomiRs” as opposed to “tumor suppressor miRs” Modulating the miRNA activities may provide exciting opportunities for cancer therapy. This review highlights the latest discovery of miRNAs involved in carcinogenesis as well as the potential applications of miRNA regulations in cancer treatment. Several studies have demonstrated the feasibility of restoring tumor suppressive miRNAs and targeting oncogenic miRNAs for cancer therapy using in vivo model systems. BioMed Central 2014-03-04 /pmc/articles/PMC4452061/ /pubmed/26056576 http://dx.doi.org/10.1186/2052-8426-2-7 Text en © Rothschild; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Rothschild, Sacha I
microRNA therapies in cancer
title microRNA therapies in cancer
title_full microRNA therapies in cancer
title_fullStr microRNA therapies in cancer
title_full_unstemmed microRNA therapies in cancer
title_short microRNA therapies in cancer
title_sort microrna therapies in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452061/
https://www.ncbi.nlm.nih.gov/pubmed/26056576
http://dx.doi.org/10.1186/2052-8426-2-7
work_keys_str_mv AT rothschildsachai micrornatherapiesincancer